Presenilins: Multifunctional proteins involved in Alzheimer's disease pathology

IUBMB Life

Volumn 48, Issue 1, 1999, Pages 33-39

  Checler, Frédéric ^a  

^a INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

APP processing; A peptide; Alzheimer's disease; Apoptosis; Caspases; Development; Embryogenesis; Maturation; Mutations; Presenilin s

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; CASPASE; GENE PRODUCT; PRESENILIN 1; PRESENILIN 2; TAU PROTEIN;

ALZHEIMER DISEASE; APOPTOSIS; CHROMOSOME 1; CHROMOSOME 14; CHROMOSOME 21; HUMAN; HUMAN CELL; HUMAN TISSUE; NEUROPATHOLOGY; PROTEIN ANALYSIS; PROTEIN INTERACTION; PROTEIN PROCESSING; REVIEW; SPECIES DIFFERENCE;

ALZHEIMER DISEASE; ANIMALS; APOPTOSIS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, PAIR 21; HUMANS; MEMBRANE PROTEINS; PRESENILIN-1; PRESENILIN-2;

EID: 0032693331     PISSN: 15216543     EISSN: None     Source Type: Journal    
DOI: 10.1080/152165499307396     Document Type: Review

References (75)

1. Tanzi, R. E., Kovacs, D. M., Kim, T.-W., Moir, R. D., Guenette, S. Y., and Wasco, W. (1996) The gene defects responsible for familial Alzheimer's disease. Neurobiol. Dis. 3, 159-168.
2. Schellenberg, G. D. (1995) Genetic dissection of Alzheimer's disease, a heterogeneous disorder. Proc. Natl. Acad. Sci. U.S.A. 92, 8552-8559.
3. Checler, F. (1995) Processing of the β-amyloid precursor protein and its regulation in Alzheimer's disease. J. Neurochem. 65, 1431-1444.
4. Selkoe, D. J. (1994) Normal and abnormal biology of the beta-amyloid precursor protein. Annu. Rev. Neurosci. 17, 489-517.
5. Ancolio, K., Dumanchin, C., Barelli, H., Warter, J. M., Brice, A., Campion, D., Frébourg, T., and Checler, F. (1999) Unusual phenotypic alteration of β-amyloid precursor protein (βAPP) maturation by a new Val → Met βAPP-770 mutation responsible for probable early-onset Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 96, 4119-4124.
6. Burdick, D., Soreghan, B., Kwon, M., Kosmoski, J., Knauer, M., Henschen, A., Yates, J., Cotman, C., and Glabe, C. (1992) Assembly and aggregation properties of synthetic Alzheimer's A4/β amyloid peptide analogs. J. Biol. Chem. 267, 546-554.
7. Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., Tsuda, T., Mar, L., Foncin, J. F., Bruni, A. C., Montesi, M. P., Sorbi, S., Rainero, I., Pinessi, L., Nee, L., Chumakov, I., Pollen, D., Brookes, A., Sanseau, P., Polinski, R. J., Wasco, W., Da Silva, H. A. R., Haines, J. L., Pericak-Vance, M. A., Tanzi, R. E., Roses, A. D., Fraser, P. E., Rommens, J. M., and St. George-Hyslop, P. H. (1995) Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375, 754-760.
8. Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D. M., Oshima, J., Pettingell, W. H., Yu, C., Jondro, P. D., Schmidt, S. D., Wang, K., Crowley, A. C., Fu, Y. H., Guenette, S. Y., Galas, D., Nemens, E., Wisjman, E. M., Bird, T. D., Schellenberg, G. D., and Tanzi, R. (1995) Candidate gene for the chromosome I familial Alzheimer's disease locus. Science 269, 973-977.
9. Rogaev, E. I., Sherrington, R., Rogaeva, E. A., Levesque, G., Ikeda, M., Liang, Y., Chi, H., Lin, C., Holman, K., Tsuda, T., Mar, L., Sorbi, S., Nacmias, B., Piacentini, S., Amaducci, L., Chumakov, I., Cohen, D., Lannfelt, L., Fraser, P. E., Rommens, J. M., and St. Georges-Hyslop, P. H. (1995) Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 376, 775-778.
10. Van Broeckhoven, C. (1995) Presenilins and Alzheimer's disease. Nat. Genet. 11, 230-232.
11. Haass, C. (1997) Presenilins: Genes for life and death. Neurons 18, 687-690.
12. Lamb, B. T. (1997) Presenilins, amyloid-β and Alzheimer's disease. Nat. Genet. 3, 28-29.
13. Hutton, M., and Hardy, J. (1997) The presenilins and Alzheimer's disease. Hum. Mol. Genet. 6, 1639-1646.
14. Mattson, M. P., Guo, Q., Furukawa, K., and Pedersen, W. A. (1998) Presenilins, the endoplasmic reticulum, and neuronal apoptosis in Alzheimer's disease. J. Neurochem. 70, 1-14.
15. Waragai, M., Imafuku, I., Takeuchi, S., Kanazawa, I., Oyama, F., Udagawa, Y., Kawabata, M., and Okazawa, H. (1997) Presenilin 1 binds to amyloid precursor protein directly. Biochem. Biophys. Res. Commun. 239, 480-482.
16. Weidemann, A., Paliga. K., Dürrwang, U., Czech, C., Evin, G., Masters, C., and Beyreuther, K. (1997) Formation of stable complexes between two Alzheimer's disease gene products: Presenilin-2 and β-amyloid precursor protein. Nat. Med. 3, 328-332.
17. Pradier, L., Carpentier, N., Delalonde, L., Clavel, N., Bock, M.-D., Buée, L., Mercken, L., Tocqué, B., and Czech, C. (1999) Mapping the APP/presenilin (PS) binding domains: The hydrophilic N-terminus of PS2 is sufficient for interaction with APP and can displace APP/PS1 interaction. Neurobiol. Dis. 6, 43-55.
18. Xia, W., Zhang, J., Perez, R., Koo, E. H., and Selkoe, D. J. (1997)Interaction between amyloid precursor protein and presenilins in mammalian cells: Implications for the pathogenesis of Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 94, 8208-8213.
19. Kim, S.-S., Choi, Y.-M., and Suh, Y.-H. (1997) Lack of interactions between amyloid precursor protein and hydrophilic domains of presenilin 1 and 2 using the yeast two hybrid system. J. Mol. Neurosci. 9, 49-54.
20. Thinakaran, G., Regard, J. B., Bouton, C. M. L., Harris, C. L., Price, D. L., Borchelt, D. R., and Sisodia, S. S. (1998) Stable association of presenilin derivatives and absence of presenilin interactions with APP. Neurobiol. Dis. 4, 438-453.
21. Yu, G., Chen, F., Levesque, G., Nishimura, M., Zhang, D.-M., Levesque, L., Rogaeva, E., Xu, D., Liang, Y., Duthie, M., St. George-Hyslop, P. H., and Fraser, P. E. (1998) The presenilin 1 protein is a component of a high molecular weight intracellular complex that contains β-catenin. J. Biol. Chem. 273, 16470-16475.
22. Tesco, G., Kim, T.-W., Dielhmann, A., Beyreuther, K., and Tanzi, R. (1998) Abrogation of the presenilin 1/β-catenin interaction and preservation of the heterodimeric presenilin 1 complex following caspase activation. J. Biol. Chem. 273, 33909-33914.
23. Zhang, Z., Hartmann, H., Do, V. M., Abramowski, D., Sturchler-Pierrat, C., Staufenbiel, M., Sommer, B., van de Wetering, M., Clevers, H., Saftig, P., De Strooper, B., He, X., and Yankner, B. A. (1998) Destabilization of β-catenin by mutations in presenilin-1 potentiates neuronal apoptosis. Nature 395, 698-702.
24. Nishimura, M., Yu, G., Levesque, G., Zhang, D. M., Ruel, L., Chen, F., Milman, P., Holmes, E., Liang, Y., Kawarai, T., Jo, E., Supala, A., Rogaeva, E., Xu, D.-M., Janus, C., Levesque, L., Bi, Q., Duthie, M., Rozmahel, R., Mattil, K., Lannfelt, L., Westaway, D., Mount, H. T. J., Woodgett, J., Fraser, P. E., and St. George-Hyslop, P. (1999) Presenilin mutations associated with Alzheimer's disease cause defective intracellular trafficking of β-catenin, a component of the presenilin protein complex. Nat. Med. 5, 164-169.
25. Levesque, G., Yu, G., Nishimura, M., Zhang, D. M., Levesque, L., Yu, H., Xu, D., Liang, Y, Rogaeva, E., Ikeda, M., Duthie, M., Murgolo, N., Wang, L., VanderVere, P., Bayne, M. L., Strader, C. D., Rommens, J. M., Fraser, P. E., and St. George-Hyslop, P. (1999) Presenilins interact with armadillo proteins including neural-specific plakophilin-related protein and β-catenin. J. Neurochem. 72, 999-1008.
26. Smine, A., Xu, X., Nishiyama, K., Katada, T., Gambetti, P., Yadav, S. P., Wu, X., Shi, Y.-C., Yasuhara, S., Homburger, V., and Okamoto, T. (1998) Regulation of brain G-protein Go by Alzheimer's disease gene presenilin-1. J. Biol. Chem. 273, 16281-16288.
27. Takashima, A., Murayama, M., Murayama, O., Kohno, T., Honda, T., Yasutake, K., Nihonmatsu, N., Mercken, M., Yamaguchi, H., Sugihara, S., and Wolozin, B. (1998) Presenilin 1 associates with glycogen synthase kinase-3β and its substrate tau. Proc. Natl. Acad. Sci. U.S.A. 95, 9637-9641.
28. Buxbaum, J. D., Choi, E.-K., Luo, Y, Lilliehook, C., Crowley, A. C., Merriam, D. E., and Wasco, W. (1998) Calsenilin: A calcium-binding protein that interacts with the presenilins and regulates the levels of a presenilin fragment. Nat. Med. 4, 1177-1181.
29. Dumanchin, C., Czech, C., Campion, D., Cuif, M.-H., Poyot, T., Charbonnier, F., Goud, B., Pradier, L., and Frebourg, T. (1999) Presenilins interact with Rabl 1, a small GTPase involved in the regulation of vesicular transport. Hum. Mol. Genet. in press.
30. Ray, W. J., Yao, M., Nowotny, P., Mumm, J., Zhang, W., Wu, J. Y., Kopan, R., and Goate, A. M. (1999) Evidence for a physical interaction between presenilin and Notch. Proc. Natl. Acad. Sci. U.S.A. 96, 3263-3268.
31. Stahl, B., Diehlmann, A., and Südhof, T. C. (1999) Direct interaction of Alzheimer's disease-related presenilin 1 with Armadillo protein p0071. J. Biol. Chem. 274, 9141-9148.
32. Dauch, P., Champigny, G., Ricci, J.-E., and Checler, F. (1997) Lack of effect of presenilin 1, βAPP and their Alzheimer's disease-related mutated forms on xenopus oocytes membrane current. Neurosci. Lett. 221, 1-4.
33. Lemere, C. A., Lopera, F., Kosik, K. S., Lendon, C. L., Ossa, J., Saido, T. C., Yamaguchi, H., Ruiz, A., Martinez, A., Madrigal, L., Hincapie, L., Arango, L. J. C., Anthony, D. C., Koo, H., Goate, A. M., Selkoe, D. J., and Arango, V. J. C. (1996) The E280A presenilin 1 Alzheimer mutation produces increased Aβ42 deposition and severe cerebellar pathology. Nat. Med. 2, 1146-1150.
34. Mann, D. M. A., Iwatsubo, T., Cairns, N. J., Lantos, P. L., Nochlin, D., Sumi, S. M., Bird, T. D., Poorkaj, P., Hardy, J., Hutton, M., Prihar, G., Crook, R., Rossor, M. N., and Haltia, M. (1997) Amyloid β protein (Aβ) deposition in chromosome 14-linked Alzheimer's disease: Predominance of Aβ42(43). Ann. Neurol. 40, 149-156.
35. Ishii, K., Ii, K., Hasegawa, T., Shoji, S., Doi, A., and Mori, H. (1997) Increased Aβ 42(43)-plaque deposition in early-onset familial Alzheimer's disease brains with the deletion of exon 9 and the missense point mutation. Neurosci. Lett. 228, 17-20.
36. Mann, D. M. A., Iwatsubo, T., Nochlin, D., Sumi, S. M., Levy-Lahad, E., and Bird, T. D. (1997) Amyloid (Aβ) deposition in chromosome 1-linked Alzheimer's disease: The Volga German family. Ann. Neurol. 41, 52-57.
37. 246) familial Alzheimer's cells. NeuroReport 7, 217-220.
38. Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., Larson, E., Levy-Lahad, E., Viitanen, M., Peskind, E., Poorkaj, P., Schellenberg, G., Tanzi, R., Wasco, W., Lannfelt, L., Selkoe, D., and Younkin, S. (1996) Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat. Med. 2, 864-870.
39. Duff, K., Eckman, C., Zehr, C., Yu, X., Prada, C.-M., Perez-Tur, J., Hutton, M., Buee, L., Harigaya, Y., Yager, D., Morgan, D., Gordon, M. N., Holcomb, L., Refolo, L., Zenk, B., Hardy, J., and Younkin, S. (1996) Increased amyloid-β42(43) in brains expressing mutant presenilin 1. Nature 383, 710-713.
40. Borchelt, D. R., Thinakaran, G., Eckman, C. B., Lee, M. K., Davenport, F., Ratovitsky, T., Prada, C.-M., Kim, G., Seekins, S., Yager, D., Slunt, H. H., Wang, R., Seeger, M., Levey, A. I., Gandy, S. E., Copeland, N. G., Jenkins, N. A., Price, D. L., Younkin, S. G., and Sisodia, S. S. (1996) Familial Alzheimer's disease-linked presenilin 1 variants elevate Aβ1-42/1-40 in vitro and in vivo. Neuron 17, 1005-1013.
41. Citron, M., Westaway, D., Xia, W., Carlson, G., Diehl, T., Levesque, G., Johnson-Wood, K., Lee, M., Seubert, P., Davis, A., Kholodenko, D., Motter, R., Sherrington, R., Perry, B., Yao, H., Strome, R., Lieberburg, I., Rommens, J., Kim, S., Schenk, D., Fraser, P., St. George-Hyslop, P., and Selkoe, D. (1997) Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice. Nat. Med. 3, 67-72.
42. Borchelt, D. R., Ratovitski, T., Van Lare, J., Lee, M. K., Gonzales, V. Jenkins, N. A., Copeland, N. G., Price, D. L., and Sisodia, S. S. (1997) Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron 19, 939-945.
43. Holcomb, L., Gordon, M. N., McGowan, E., Yu. X., Benkovic, S., Jantzen, P., Wright, K., Saad, I., Mueller, R., Morgan, D., Sanders, S., Zehr, C., O'Campo, K., Hardy, J., Prada, C.-M., Eckman, C., Younkin, S., Hsiao, K., and Duff, K. (1998) Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat. Med. 4, 97-100.
44. Xia, W., Zhang, J., Kholodenko, D., Citron, M., Podlisny, M. B., Teplow, D. B., Haass, C., Seubert, P., Koo, E. H., and Selkoe, D. J. (1997) Enhanced production and oligomerization of the 42-residue amyloid β-protein by Chinese hamster ovary cells stably expressing mutant presenilins. J. Biol. Chem. 272, 7977-7982.
45. Ancolio, K., Marambaud, P., Dauch, P., and Checler, F. (1997) α-Secretase-derived product of β-amyloid precursor protein is decreased by presenilin 1 mutations linked to familial Alzheimer's disease. J. Neurochem. 69, 2494-2499.
46. Barelli, H., Lebeau, A., Vizzavona, J., Delaere, P., Chevallier, N., Drouot, C., Marambaud, P., Ancolio, K., Buxbaum, J. D., Khorkova, O., Heroux, J., Sahasrabudhe, S., Martinez, J., Warter, J.-M., Mohr, M., and Checler, F. (1997) Characterization of new polyclonal antibodies specific for 40 and 42 amino acid-long amyloid β peptides: Their use to examine the cell biology of presenilins and the immunohistochemistry of sporadic Alzheimer's disease and cerebral amyloid angiopathy cases. Mol. Med. 3, 695-707.
47. Tomita, T., Maruyama, K., Saido, T. C., Kume, H., Shinozaki, K. T. S., Capell, A., Walter, J., Grünberg, J., Haass, C., Iwatsubo, T., and Obata, K. (1997) The presenilin 2 mutation (N141I) linked to familial Alzheimer disease (Volga German families) increases the secretion of amyloid β protein ending at the 42nd (or 43rd) residue. Proc. Natl. Acad. Sci. U.S.A. 94, 2025-2030.
48. Marambaud, P., Alves da Costa, C., Ancolio, K., and Checler, F. (1998) Alzheimer's disease-linked mutation of presenilin 2 (N141I-PS2) drastically lowers APPα secretion: Control by the proteasome. Biochem. Biophys. Res. Commun. 252, 134-138.
49. De Strooper, B., Saftig, P., Craessaerts, K., Vanderstichele, H., Guhde, G., Von Figura, K., and Van Leuven, F. (1998) Deficiency of presenilin 1 inhibits the normal cleavage of amyloid precursor protein. Nature 391, 387-390.
50. De Strooper, B., Annaert, W., Cupers, P., Saftig, P., Craessaerts, K., Mumm, J. S., Schroeter, E. H., Schrijvers, V., Wolfe, M. S., Ray, W. J., Goale, A., and Kopan, R. (1999) A presenilin-1-dependent γ-secretase-like protease mediates release of Notch intracellular domain. Nature 398, 518-522.
51. Naruse, S., Thinakaran, G., Luo, J.-J., Kusiak, J. W. T. T., Iwatsubo, T., Qian, X., Ginty, D. D., Price, D. L., Borchelt, D. R., Wong, P. C., and Sisodia, S. S. (1998) Effects of PS1 deficiency on membrane protein trafficking in neurons. Neuron 20, 1213-1221.
52. Marambaud, P., Ancolio, K., Lopez-Perez, E., and Checler, F. (1998) Proteasome inhibitors prevent the degradation of familial Alzheimer's disease-linked presenilin 1 and trigger increased Aβ42 secretion by human cells. Mol. Med. 4, 147-157.
53. 2+-binding protein ALG-2 and Alzheimer's disease gene ALG-3. Science 271, 521-525.
54. Wolozin, B., Iwasaki, K., Vito, P., Ganjei, J. K., Lacana, E., Sunderland, T., Zhao, B., Kusiak, J. W., Wasco, W., and D'Adamio, L. (1996) Participation of presenilin 2 in apoptosis: Enhanced basal activity conferred by an Alzheimer mutation. Science 274, 1710-1713.
55. Janicki, S., and Monteiro, M. J. (1997) Increased apoptosis arising from increased expression of the Alzheimer's disease associated presenilin-2 mutation (N141I). J. Cell Biol. 139, 485-495.
56. Deng, G., Pike, C. J., and Cotman, C. W. (1996) Alzheimer-associated presenilin-2 confers increased sensitivity to apoptosis in PC12 cells. FEBS Lett. 397, 50-54.
57. Vito, P., Wolozin, B., Ganjei, J. K., Iwasaki, K., Lacana, E., and D'Adamio, L. (1996) Requirement of the familial Alzheimer's disease gene PS2 for apoptosis. Opposing effect of ALG-3. J Biol. Chem. 271, 31025-31028.
58. Vito, P., Ghayur, T., and D'Adamio, L. (1997) Generation of anti-apoptotic presenilin-2 polypeptides by alternative transcription, proteolysis, and caspase-3 cleavage. J. Biol. Chem. 272, 28315-28320.
59. Walter, J., Schindzielorz, A., Grünberg, J., and Haass, C. (1999) Phosphorylation of presenilin-2 regulates its cleavage by caspases and retards progression of apoptosis. Proc. Natl. Acad. Sci. U.S.A. 96, 1391-1396.
60. Kim, T.-W., Pettingell, W. H., Jung, Y.-K., Kovacs, D. M., and Tanzi, R. E. (1997) Alternative cleavage of Alzheimer-associated presenilins during apoptosis by a caspase-3 family protease. Science 277, 373-376.
61. Guo, Q., Sopher, B. L., Furukawa, K., Pham, D. G., Robinson, N., Martin, G. M., and Mattson, M. P. (1997) Alzheimer's presenilin mutation sensitizes naural cells to apoptosis induced by trophic factor withdrawal and amyloid β-peptide: involvement of calcium and oxyradicals. J. Neurosci. 17, 4212-4222.
62. Bursztajn, S., DeSouza, R., McPhie, D. L., Berman, S. A., Shioi, J., Robakis, N. K., and Neve, R. L. (1998) Overexpression in neurons of human presenilin-1 or a presenilin-1 familial Alzheimer's disease mutant does not enhance apoptosis. J. Neurosci. 18, 9790-9799.
63. Hong, C.-S., Caromile, L., Nomata, Y., Mori, H., Bredesen, D. E., and Koo, E. H. (1999) Contrasting role of presenilin-1 and presenilin-2 in neuronal differentiation in vitro. J. Neurosci. 19, 637-643.
64. Levitan, D., and Greenwald, I. (1995) Facilitation of lin-12-mediated signalling by sel-12, a Caenorhabditis elegans S182 Alzheimer's disease gene. Nature 377, 351-354.
65. Baumeister, R., Leimer, U., Zweckbronner, I., Jakubek, C., Grünberg, J., and Haass, C. (1997) Human presenilin-1 but not familial Alzheimer's disease (FAD) mutants, facilitate Caenorhabditis elegant Notch signalling independently of proteolytic processing. Genes Func. 1, 149-159.
66. Levitan, D., Doyle, T. G., Brousseau, D., Lee, M. K., Thinakaran, G., Slunt, H. H., Sisodia, S. S., and Greenwald, I. (1996) Assessment of normal and mutant human presenilin function in Caenorhabditis elegans. Proc. Natl. Acad. Sci. U.S.A. 93, 14940-14944.
67. Wong, P. C., Zheng, H., Chen, H., Becher, M. W., Sirinathsinghji, D. J. S., Trumbauer, M. E., Chen, H. Y, Price, D. L., Van der Ploeg, L. H. T., and Sisodia, S. S. (1997) Presenilin 1 is required for Notch1 and DII 1 expression in the paraaxial mesoderm. Nature 387, 288-292.
68. Shen, J., Bronson, R. T., Chen, D. F., Xia, W., Selkoe, D., and Tonegawa, S., (1997) Skeletal and CNS detects in presenilin-1-deficient mice. Cell 89, 629-639.
69. Qian, S., Jiang, P., Guan, X., Sing, G., Trumbauer, S. M., Yu, H., Chen, H. Y., Van der Ploeg, L. H. T., and Zheng, H. (1998) Mutant human presenilin 1 protects presenilin-1 null mouse against embryonic lethality and elevates Aβ1-42/43 expression. Neuron 20, 611-617.
70. Davis, J. A., Naruse, S., Chen, H., Eckman, C., Younkin, S., Price, D. L., Borchelt, D. R., Sisodia, S. S., and Wong, P. C. (1998) An Alzheimer's disease-linked PS1 variant rescues the developmental abnormalities of PS1 - deficient embryos. Neuron 20, 603-609.
71. Zhang, W., Han, S. W., McKeel, D. W., Goate, A., and Wu, J. Y. (1998) Interaction of presenilins with the filamin family of actin-binding proteins. J. Neurosci. 18, 914-922.
72. Struhl, G., and Greenwald, I. (1999) Presenilin is required for activity and nuclear access of Notch in Drosophila. Nature 398, 522-525.
73. Ye, Y., Lukinova, N., and Fortini, M. E. (1999) Neurogenic phenotypes and altered Notch processing in Drosophila presenilin mutants. Nature 398, 525-529.
74. Wolfe, M. S., Xia, W., Ostaszewski, B. L., Diehl, T. S., Kimberly, W. T., and Selkoe, D. J. (1999) Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and γ-secretase activity. Nature 398, 513-517.
75. Goedert, M. (1993) Tau protein and the neurofibrillary pathology of Alzheimer's disease. TINS 16, 460-465.